Clinical trial · Observational
Plasma Metanephrines in Patients With Cyanotic and Acyanotic Congenital Heart Disease
NCT04891081CI-TRIAL-00051854unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of our study is to compare plasma metanephrines in patients with cyanotic and acyanotic congenital heart disease and possible association with chronic hypoxic stress.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Acyanotic Congenital Heart Disease | — | UNRESOLVED | — |
| Cyanotic Congenital Heart Disease | — | UNRESOLVED | — |
| Paraganglioma | Paraganglioma | ONTOLOGY_EXACT | 0.98 |
| Pheochromocytoma | Adrenal Gland Pheochromocytoma | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- Patients with cyanotic Congenital Heart Disease
- label
- Patients with acyanotic Congenital Heart Disease
Primary outcomes (2)
- measure
- Plasma metanephrine level
- timeFrame
- baseline, one point of time in a cross-sectional study
- description
- Level of plasma metanephrine
- measure
- Plasma normetanephrine level
- timeFrame
- baseline, one point of time in a cross-sectional study
- description
- Level of plasma normetanephrine
Secondary outcomes (1)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * patients with congenital heart disease attending regular follow up Exclusion Criteria: * missing main data in medical documentation
References
Publications (0)
Data not yet available
No reference posted for this study.